Compounds, compositions and methods of using same for modulating uric acid levels

Details for Australian Patent Application No. 2012209027 (hide)

Owner Ardea Biosciences, Inc.

Inventors Gunic, Esmir; Girardet, Jean-Luc; Paisner, David A.

Agent Shelston IP

Pub. Number AU-A-2012209027

Parent 2009289646

Filing date 31 July 2012

Wipo publication date 23 August 2012

International Classifications

C07D 233/42 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/44 - Non-condensed pyridines

A61P 3/00 Drugs for disorders of the metabolism

C07D 233/30 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

16 August 2012 Complete Application Filed

23 August 2012 Application Open to Public Inspection

  Published as AU-A-2012209027

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012209028-Image processing apparatus and method, specifying mark estimating apparatus and method, and program

2012209026-Image processing apparatus, image processing method, and program